ask="2.75"
ask_size="100"
average_daily_volume="348045"
bid="N/A"
bid_size="N/A"
book_value="0.88"
change="+0.10"
change_from_200_day_moving_average="-1.61"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-4.73"
change_From_52_week_low="0.43"
change_in_percent="+4.76%"
close="2.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.11"
ex_dividend_date="N/A"
float_shares="25714000"
high="2.20"
high_52_weeks="6.93"
last_trade_date="2/2/2017"
last_trade_price="2.20"
last_trade_size="3017"
last_trade_time="4:00pm"
low="2.08"
low_52_weeks="1.77"
market_capitalization="67.35M"
moving_average_200_day="3.81"
moving_average_50_day="2.19"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="2.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-42.32%"
percent_change_from_50_day_moving_average="+0.26%"
percent_change_from_52_week_high="-68.25%"
percent_change_from_52_week_low="+23.94%"
previous_close="2.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="163.94"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="5.69"
stock_exchange="NCM"
symbol="TROV"
volume="113370"
weeks_range_52="1.77 - 6.93"
